[1]
Shivakumar, R. et al. 2026. Pyrimidine-Piperazine Hybrids as Potential PARP1 Inhibitors: Dual in silico and in vitro Approaches against Breast Cancer. Asian Journal of Chemistry. 38, 4 (Apr. 2026), 956–962. DOI:https://doi.org/10.14233/ajchem.2026.35478.